|
1
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghajar CM: Metastasis prevention by
targeting the dormant niche. Nat Rev Cancer. 15:238–247. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ettinger DS, Akerley W, Bepler G, Blum MG,
Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, et
al: Non-small cell lung cancer. J Natl Compr Canc Netw. 8:740–801.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanoue LT, Tanner NT, Gould MK and
Silvestri GA: Lung cancer screening. Am J Respir Crit Care Med.
191:19–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
David CJ, Huang YH, Chen M, Su J, Zou Y,
Bardeesy N, Iacobuzio-Donahue CA and Massagué J: TGF-β tumor
suppression through a lethal EMT. Cell. 164:1015–1030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu JR, Tai Y, Jin Y, Hammell MC, Wilkinson
JE, Roe JS, Vakoc CR and Van Aelst L: TGF-β/Smad signaling through
DOCK4 facilitates lung adenocarcinoma metastasis. Genes Dev.
29:250–261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Wang L, Zhao J, Chen Y, Lei Z, Liu
X, Xia W, Guo L and Zhang HT: TGF-β-activated SMAD3/4 complex
transcriptionally upregulates N-cadherin expression in non-small
cell lung cancer. Lung Cancer. 87:249–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang WC, Ren JL, Wong CW, Chan SO, Waye
MM, Fu WM and Zhang JF: LncRNA-NEF antagonized epithelial to
mesenchymal transition and cancer metastasis via cis-regulating
FOXA2 and inactivating Wnt/β-catenin signaling. Oncogene.
37:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rami-Porta R, Asamura H, Travis WD and
Rusch VW: Lung cancer-major changes in the American Joint Committee
on Cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng Z, Zhang C and Duan C: Functions and
mechanisms of long noncoding RNAs in lung cancer. Onco Targets
Ther. 9:4411–4424. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niu Y, Ma F, Huang W, Fang S, Li M, Wei T
and Guo L: Long non-coding RNA TUG1 is involved in cell growth and
chemoresistance of small cell lung cancer by regulating LIMK2b via
EZH2. Mol Cancer. 16:52017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng L, Yang R, Wang J and Liu Y: The
relationship between the expression of LncRNA EXOC7 and the
prognosis of patients with small cell lung cancer. Tumor.
37:269–274. 2017.
|
|
17
|
Wan L, Zhang L, Fan K and Wang JJ:
Diagnostic significance of circulating long noncoding RNA PCAT6 in
patients with non-small cell lung cancer. Onco Targets Ther.
10:5695–5702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
19
|
Akhurst RJ and Derynck R: TGF-beta
signaling in cancer-a double-edged sword. Trends Cell Biol.
11:S44–S51. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seoane J and Gomis RR: TGF-β family
signaling in tumor suppression and cancer progression. Cold Spring
Harb Perspect Biol. 9(pii): a0222772017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Yang H, Lei Z, Zhao J, Chen Y,
Chen P, Li C, Zeng Y, Liu Z, Liu X and Zhang HT: Repression of
TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal
transition in non-small-cell lung cancer. Oncogene. 35:867–877.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang D, Qin H, Leng Y, Li X, Zhang L, Bai
D, Meng Y and Wang J: LncRNA MEG3 overexpression inhibits the
development of diabetic retinopathy by regulating TGF-β1 and VEGF.
Exp Ther Med. 16:2337–2342. 2018.PubMed/NCBI
|
|
23
|
Zhao B, Lu YL, Yang Y, Hu LB, Bai Y, Li
RQ, Zhang GY, Li J, Bi CW, Yang LB, et al: Overexpression of lncRNA
ANRIL promoted the proliferation and migration of prostate cancer
cells via regulating let-7a/TGF-β1/Smad signaling pathway. Cancer
Biomark. 21:613–620. 2018. View Article : Google Scholar : PubMed/NCBI
|
